DAIHAN PHARMACEUTICAL revenue for the last year amounted to 195.90 B KRW, the most of which — 151.20 B KRW — came from its highest performing source at the moment, SAP Products, the year earlier bringing 141.16 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought DAIHAN PHARMACEUTICAL 195.91 B KRW, and the year before that — 184.27 B KRW.